A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

China has pulled ahead of the United States in key areas of the life sciences, and the U.S. may only have a handful of years ...

On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...

A team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

A company recently claimed it revived an extinct species, launching a debate across scientific and conservation communities.

Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "China Biotechnology Directory 2025" has been added to ResearchAndMarkets.com's offering. The Chinese biotechnology industry has increased with high ...

Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...